The Myotonic Dystrophy Foundation supports scientific investigations to enhance the quality of life of people living with myotonic dystrophy and advance research focused on finding treatments and a cure for this disease. As a part of this effort, the Foundation offers a number of funding opportunities for DM researchers. Visit this page regularly or subscribe to the DM Research News to stay current on funding opportunities from MDF and the Wyck Foundation.
Current Funding Opportunities
Request for Applications
The Wyck Foundation and the Myotonic Dystrophy Foundation have partnered to offer training fellowships, and are pleased to announce that the 2019 Request for Applications is now open. MDF is expanding the scientific research endeavors eligible for Ph.D. Trainee and Postdoctoral Fellowship awards to include research focused on improving treatment, care and support of the DM patient and his/her family, as well as molecular biology and basic science. Trainees working in academia, research institutes or drug development companies are eligible.
Applications are due by September 3, 2018, with a start date for successful applicants of January 2019. Applicants are encouraged to contact the MDF Chief Science Officer, Dr. Elizabeth Ackermann, with any questions about this RFA or the scientific content of their proposals. Technical issues should be directed to MDF Grants Manager Elizabeth Habeeb-Louks.
Request for Proposals
The Myotonic Dystrophy Foundation (MDF) is pleased to announce a Request for Proposals to establish a mouse drug testing facility for myotonic dystrophy type 1 (DM1). MDF intends to support the establishment of a contract-based testing facility by funding activities necessary to set up efficacy testing in the HSA-LR model of DM1 (Mankodi et al., 2000). The facility would then operate under contracts from drug developers and academics to ensure independent and rigorous testing of candidate therapeutics.
Applications are due by May 7, 2018, with a start date for successul applicants of September 1, 2018. Applicants are encouraged to contact the MDF Chief Science Officer, Dr. Elizabeth Ackermann, with any questions about this RFP or the scientific content of their proposals. Technical issues should be directed to MDF Grants Manager Elizabeth Habeeb-Louks.
MDF Grant Awards
Click here to view a list of current and former grantees, grant projects and Fellows.
Grantwriting Training for Researchers
MDF annually hosts a grant writing training at the MDF Annual Conference. In 2016, the session was presented by Tom Cheever, PhD, Program Director at the National Institute of Arthritis and Musculoskeletal, and Skin Diseases (NIAMS). In 2017, the session was presented by MDF Chief Science Officer John Porter, PhD, former Program Director at the National Institute of Neuromuscular Disorders and Stroke (NINDS) at the U.S. National Institutes of Health (NIH). View the presentation slides from Dr. Cheever (presentation slides) and Porter (presentation slides) from those training and access best-in-class grantwriting tips.
Subscribe to MDF's research news publication, DM Research News, for updates about MDF and other funding opportunities. If you are not signed up for and receiving the DM Research News, send us an email with your name, degree, institution and current work or interest in DM care, research and/or drug development and we will enroll you in the monthly newsletter.
Email MDF's Chief Scientific Officer, Dr. Elizabeth Ackermann.
For more information on MDF grantmaking policies, click here to read the MDF Request for Proposals Award Policy manual.